Patents by Inventor Khadijah Mohammad

Khadijah Mohammad has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Potent antimicrobial compounds with a pyridazine nucleus
    Patent number: 11648248
    Abstract: Anti-microbial compounds having a pyridazine nucleus are provided. The compounds have anti-microbial (anti-biotic) properties and are used to treat infections caused by microbes, especially bacteria that are resistant to known antibiotics e.g. drug resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA).
    Type: Grant
    Filed: January 12, 2022
    Date of Patent: May 16, 2023
    Assignee: King Abdulaziz University
    Inventors: Moustafa El-Araby, Khaled Abouzid, Abdelsattar Omar, Maiy Jaballah, Khadijah Mohammad
  • Arylacetamides as AMP-activated protein kinase inhibitors and their use for treatment of breast cancer
    Patent number: 11479536
    Abstract: Therapeutic compounds containing an arylacetamide core pending N-benzyl group. Also described are pharmaceutical compositions incorporating the therapeutic compounds and a method for inhibiting AMP-activated kinase (AMPK) and their use thereof for treating breast and pancreatic cancer with the specified compounds.
    Type: Grant
    Filed: April 27, 2022
    Date of Patent: October 25, 2022
    Assignee: KING ABDULAZIZ UNIVERSITY
    Inventors: Abdelsattar M. Omar, Mohammad Imran Khan, Moustafa Elsayed El-Araby, Mahmood Hassan Dalhat, Mohammed Razeeth S. Mohammed, Majed Abdullah A. Alharbi, Yosra A. Muhammad, Hani Mohammed Z. Choudhry, Amer Hamzah O. Asseri, Khadijah A. Mohammad, Maan T. Khayat